Partnership Forum: This forum identified challenges and payer needs related to the evidence for digital therapeutics. The forum explored the current market space for digital therapeutics including the evidence for the products, place in therapy, monitoring or utilization metrics and barriers that patients face in obtaining therapies.
AMCP will occasionally publish highlights from AMCP and other conferences designed for those in managed care pharmacy. Highlights include summaries of select featured session and posters. Meetings published currently include the AAD Virtual Meeting, ASCO Virtual Scientific Program, Assembia 2020, AMCP eLearning Days, NAMCP, AAAAI Annual Meeting, 2019 ACR/ERP Annual Meeting and AMCP Nexus 2019.
Partnership Forum: Now more than ever, there is an increased focus on health disparities that occur across a multitude of factors, including socioeconomic status, ethnicity, and race. This forum helped identify potential structural issues within the current formulary and benefit design processes that may have led to racial health disparities or inequality.
Partnership Forum: The market for biologic drugs in the United States is large and has the potential to play an increasingly important role in the country’s health care system — both in the treatment of disease and in the affordability of drugs. Biosimilar approval and marketing of products in the United States is at a slower pace than desired by many stakeholders. This forum helped identify key actions that could support the further development and use of biologics in the U.S. health care system.
Headache is one of the most common symptoms in the general population, but despite its high prevalence and impairment, migraine is often not recognized or effectively treated. To understand the appropriate and cost-effective use of novel treatments for migraine headaches, AMCP convened an expert forum of stakeholders.
Partnership Forum: Participants considered the possible solutions for addressing rising costs and discussed challenges, practical steps for implementing point of sale rebates and other proposed solutions, and discussed how patient assistance programs and copay policies fit into the affordability equation. This forum will develop recommendations and possible solutions to improve price transparency, address the rising costs of medications, and help patient understand and manage drug cost.